Skip to content
Triangle logo TriangleGet started
← Malignant Fallopian Tube Neoplasm

NCT00870233 · STUDY IN CONTEXT

Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life

Draft scope assessment: narrower. Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm. Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.

Read the full study record and all posted results →

Linked outcomes

Measures are not ranked. Open each original source section for treatment groups, denominators, units and results.

primary · POSTED

Feasibility of Electronic Capture of Patient-reported Symptoms From Home Following Major Gynecologic Cancer Surgery

Source null

→

secondary · POSTED

Feasibility of Online Symptom Self-reporting in the Early Postoperative Period, and Clinician Perceptions of Its Potential Value in Routine Outpatient Post-operative Cancer Care.

Nurses who participated in the study

→

secondary · POSTED

To Evaluate the Impact of Online Symptom Self-reporting on Patient Care Processes as Measured by the Number of Telephone Calls Between Nurses and Patients,Resulting Interventions and Patient Satisfaction With Care Delivery.

Data were not collected

→

secondary · POSTED

The percentage of symptoms generated by patients on protocol

Source null

→

Reported safety

Serious events are not the same as severe events. Compare the original safety groups and their at-risk populations.

Open the study safety table →

Quality of life and patient-reported measures

Patient-reported symptom or function measure · Feasibility of Electronic Capture of Patient-reported Symptoms From Home Following Major Gynecologic Cancer Surgery

Score direction: Not stated by the study. Direction is never inferred from an instrument name.

release id
clinical-indications-draft-1
disease state id
ds-malignant-fallopian-tube-neoplasm
nct id
NCT00870233
qol key
qol-0000
source section id
NCT00870233-om-0000
source outcome index
0
instrument
Patient-reported symptom or function measure
instrument basis
matched 'patient-reported' in the study's own wording
scale title
Feasibility of Electronic Capture of Patient-reported Symptoms From Home Following Major Gynecologic Cancer Surgery
measure definition
Source null
time frame
once pre-operatively and then weekly starting 7 days after surgery until the 6-week post-operative period has ended.
analysis role
primary
reporting status
POSTED
higher is better
Source null
direction quote
Source null
population note
Source null
curation status
draft
reviewed by
Source null
reviewed at
Source null
created at
2026-09-10T00:00:00Z
Open the exact result →
Full draft applicability and source-link record
trial
release id
clinical-indications-draft-1
disease state id
ds-malignant-fallopian-tube-neoplasm
nct id
NCT00870233
trial label
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
applicability
narrower
applicability note
Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm.
curation status
draft
reviewed by
Source null
reviewed at
Source null
created at
2026-09-10T00:00:00Z
provenance class
registry-condition-search
discovery note
Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
outcome Count
4
harms Count
1
qol Count
1
outcomes
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0000
    source section id
    NCT00870233-om-0000
    source outcome index
    0
    endpoint
    Feasibility of Electronic Capture of Patient-reported Symptoms From Home Following Major Gynecologic Cancer Surgery
    endpoint definition
    Feasibility of Electronic Capture of Patient-reported Symptoms From Home Following Major Gynecologic Cancer Surgery
    time origin
    once pre-operatively and then weekly starting 7 days after surgery until the 6-week post-operative period has ended.
    analysis role
    primary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0001
    source section id
    NCT00870233-om-0001
    source outcome index
    1
    endpoint
    Feasibility of Online Symptom Self-reporting in the Early Postoperative Period, and Clinician Perceptions of Its Potential Value in Routine Outpatient Post-operative Cancer Care.
    endpoint definition
    Feasibility of Online Symptom Self-reporting in the Early Postoperative Period, and Clinician Perceptions of Its Potential Value in Routine Outpatient Post-operative Cancer Care.
    time origin
    once pre-operatively and then weekly starting 7 days after surgery until the 6-week post-operative period has ended
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Nurses who participated in the study
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0002
    source section id
    NCT00870233-om-0002
    source outcome index
    2
    endpoint
    To Evaluate the Impact of Online Symptom Self-reporting on Patient Care Processes as Measured by the Number of Telephone Calls Between Nurses and Patients,Resulting Interventions and Patient Satisfaction With Care Delivery.
    endpoint definition
    To Evaluate the Impact of Online Symptom Self-reporting on Patient Care Processes as Measured by the Number of Telephone Calls Between Nurses and Patients,Resulting Interventions and Patient Satisfaction With Care Delivery.
    time origin
    two years
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Data were not collected
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  4. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0003
    source section id
    NCT00870233-om-0003
    source outcome index
    3
    endpoint
    Most Commonly Reported and Most Distressing Symptoms Reported by Patients After Gynecologic Cancer Surgery Using the STAR System
    endpoint definition
    The percentage of symptoms generated by patients on protocol
    time origin
    weekly starting 7 days after surgery until the 6-week post-operative period
    analysis role
    secondary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
arms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0000
    arm key
    OG000
    arm label
    GYN Pts Undergoing Surgery
    regimen
    This study will assess patient use of WEBCORE, an online system designed for cancer patients to self-record toxicity-related symptoms based on NCI Common Terminology Criteria for Adverse Events and global quality of life (QoL) by European Organization for Research and Treatment of Cancer (EORTC QLQ-C30). online platform WEBCORE: Enrollees will be sent weekly email reminders to login to WEBCORE from home. Participants will be expected to complete the questionnaire once pre-operatively and then weekly starting 7 days after surgery until the 6-week post-operative period has ended.
    analyzed count
    120
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00870233-om-0000#groups/OG000
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0001
    arm key
    OG000
    arm label
    Study Nurse Clinicians
    regimen
    Email alerts were sent to study nurses when concerning participant responses were entered. The nurse assessments of STAR's usefulness were measured via an exit survey. Alerts were considered concerning according to pre-specified limits set by the Gynecologic Oncology Service. This is the same system presently used to triage patient phone calls. Any actions taken by the nurses in response to these alerts were recorded. However, specific responses were not required. Patients were encouraged to call their physician's office if medical attention was needed, as there was no regularly scheduled monitoring of information entered into the STAR system.
    analyzed count
    9
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00870233-om-0001#groups/OG000
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0002
    arm key
    OG000
    arm label
    GYN Pts Undergoing Surgery
    regimen
    This study will assess patient use of WEBCORE, an online system designed for cancer patients to self-record toxicity-related symptoms based on NCI Common Terminology Criteria for Adverse Events and global quality of life (QoL) by European Organization for Research and Treatment of Cancer (EORTC QLQ-C30). online platform WEBCORE: Enrollees will be sent weekly email reminders to login to WEBCORE from home. Participants will be expected to complete the questionnaire once pre-operatively and then weekly starting 7 days after surgery until the 6-week post-operative period has ended.
    analyzed count
    0
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00870233-om-0002#groups/OG000
  4. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    outcome key
    om-0003
    arm key
    OG000
    arm label
    GYN Pts Undergoing Surgery
    regimen
    This study will assess patient use of WEBCORE, an online system designed for cancer patients to self-record toxicity-related symptoms based on NCI Common Terminology Criteria for Adverse Events and global quality of life (QoL) by European Organization for Research and Treatment of Cancer (EORTC QLQ-C30). online platform WEBCORE: Enrollees will be sent weekly email reminders to login to WEBCORE from home. Participants will be expected to complete the questionnaire once pre-operatively and then weekly starting 7 days after surgery until the 6-week post-operative period has ended.
    analyzed count
    120
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT00870233-om-0003#groups/OG000
harms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    harm key
    EG000
    source section id
    NCT00870233-ae
    event group key
    EG000
    event group label
    GYN Pts Undergoing Surgery
    serious affected
    0
    serious at risk
    120
    other affected
    85
    other at risk
    120
    frequency threshold
    0
    collection period
    Up to 16 weeks (between 6-8 weeks post surgery)
    event definition
    Source null
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
quality of life
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-malignant-fallopian-tube-neoplasm
    nct id
    NCT00870233
    qol key
    qol-0000
    source section id
    NCT00870233-om-0000
    source outcome index
    0
    instrument
    Patient-reported symptom or function measure
    instrument basis
    matched 'patient-reported' in the study's own wording
    scale title
    Feasibility of Electronic Capture of Patient-reported Symptoms From Home Following Major Gynecologic Cancer Surgery
    measure definition
    Source null
    time frame
    once pre-operatively and then weekly starting 7 days after surgery until the 6-week post-operative period has ended.
    analysis role
    primary
    reporting status
    POSTED
    higher is better
    Source null
    direction quote
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
setting source links

    Preserved source evidence · Not medical advice